Home Physical Sciences Pentavalent rhenium-188 dimercaptosuccinic acid: a new kit formulation and its initial evaluation in mice
Article
Licensed
Unlicensed Requires Authentication

Pentavalent rhenium-188 dimercaptosuccinic acid: a new kit formulation and its initial evaluation in mice

  • , , , , and
Published/Copyright: September 25, 2009

Pentavalent rhenium-188 dimercaptosuccinic acid [188Re(V)DMSA] is a β-emitting radiopharmaceutical that has been proposed for the treatment of painful bone metastases, medullary thyroid carcinoma and other soft tissue tumours. In this study the development of a kit formulation for convenient, routine preparation of 188Re(V)DMSA is presented. The kit contains all the ingredients in a single vial and its reconstitution with 188Re perrhenate, up to 4;mL, produces 188Re(V)DMSA in high radiochemical purity, suitable for clinical application. 188Re(V)DMSA prepared by this kit method was evaluated in mice and resulted in a biodistribution pattern similar to that of 99mTc(V)DMSA.

Published Online: 2009-9-25
Published in Print: 2001-2-1

© 2015 Oldenbourg Wissenschaftsverlag GmbH, Rosenheimer Str. 145, 81671 München

Downloaded on 2.4.2026 from https://www.degruyterbrill.com/document/doi/10.1524/ract.2001.89.2.115/html
Scroll to top button